Category: hydroxychloroquine
FDA reiterates risks of antimalarial drug use for COVID-19, as study into efficacy ends early due to deaths
The U.S. Food and Drug Administration (FDA) has issued a new warning about the known side effects of hydroxychloroquine and chloroquine, two antimalarial drugs (also used in the treatment of chronic rheumatoid arthritis and lupus), on the same day that a group of researchers published a paper in the Journal…
Read More
Henry Ford Health System to conduct first large U.S. study of hydroxychloroquine’s ability to prevent COVID-19
Despite false assertions by the President to the contrary, any potential treatments to counter or prevent COVID-19 are still only at the stage of early investigations, which include one-off treatment with special individual case authorizations, and small-scale clinical examinations. Nothing so far has approached the level of scrutiny needed to…
Read More
New study casts doubt on hyrdoxychloroquine’s effectiveness in treating coronavirus
In a prime example of why President Trump shouldn’t be endorsing any unproven potential treatments for the novel coronavirus behind the current global pandemic, a new small-scale study by researchers in China indicates that the antimalarial drug hydroxychloroquine actually isn’t any more effective than standard, existing best practice for conventional…
Read More